DOXGX | EICVX | DOXGX / EICVX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 3 years | 14 years | - |
Gain YTD | 3.705 | 3.032 | 122% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 112B | 294M | 38,095% |
Annual Yield % from dividends | 1.45 | 3.30 | 44% |
Returns for 1 year | 12.29 | 8.70 | 141% |
Returns for 3 years | N/A | 8.65 | - |
Returns for 5 years | N/A | 34.65 | - |
Returns for 10 years | N/A | 45.34 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HLEMX | 35.82 | 0.19 | +0.53% |
Harding Loevner Emerging Markets Advisor | |||
EIVAX | 13.63 | 0.07 | +0.52% |
Allspring Special Large Cap Value A | |||
MSHPX | 13.44 | 0.07 | +0.52% |
Morgan Stanley Inst Permanence R6 | |||
LSVVX | 13.91 | 0.07 | +0.51% |
LSV Conservative Value Equity | |||
FSMEX | 65.43 | 0.11 | +0.17% |
Fidelity Select Medical Tech and Devcs |